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The isolated perfused rat lung catalyzed the biosynthesis of GSH when the sulfur amino acids cysteine or 
iV-acetylcysteine, butnot methionine, were supplied in the perfusion medium. The lung also had the capacity 
to utilize extracellular GSH for this purpose. Replenishment of intracellular GSH in perfused lungs from 
diethylmaleate-treated rats was pronounced even at 25 PM GSH in the perfusion medium. The utilization 
of extracellular GSH is probably primarily through extracellular breakdown and resynthesis rather than 
direct uptake as indicated by the inhibitory effect of the y-glutamylcysteine synthetase inhibitor, buthionine 
sulfoximine and the y-glutamyl transferase inhibitor, anthglutin. The results indicate that the lung in 
addition to the kidney may utilize circulating plasma GSH. 
GSH Perfurd lung Biosynthesis 
1. INTRODUCTION 
The biosynthesis of glutathione (GSH) in mam- 
malian liver and kidney has been the subject of ex- 
tensive study in the past [l]. There exists a con- 
siderable intra- and interorgan heterogeneity in the 
utilization of sulfur amino acid precursors of cys- 
teine for the biosynthesis of GSH. Whereas the 
liver has the ability to synthesize cysteine from 
intra-cellular methionine and glycine via the 
cystathionase pathway [2], neither extra-cellular 
cystine nor GSH can serve as cysteine precursors in 
this organ. Alternatively, the kidney utilizes both 
cystine and GSH for this purpose and appears to 
lack the cystathionase pathway [5,6]. 
The kidney is thus the primary organ utilizing 
circulating plasma GSH [7,8], which is predomin- 
antly released from the liver [8,9]. It has been 
estimated that approx. 2/3 of the breakdown of 
plasma GSH is due to renal y-glutamyl-transpepti- 
dase activity [lo]. The lung may also contribute to 
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the utilization of plasma GSH as indicated by the 
finding that isolated lung cells and isolated per- 
fused lung from rat have the ability to utilize extra- 
cellular GSH for glutathione conjugation [ 111. 
We examined the ability of the perfused rat lung 
to utilize different sulfur amino acids for GSH 
biosynthesis. The mechanism by which extracell- 
ular GSH is utilized for this purpose is also dis- 
cussed. 
2. MATERIALS AND METHODS 
Glutathione (oxidized and reduced), amino 
acids, diethylmaleate and bovine serum albumin 
(fraction V) were all purchased from Sigma (St. 
Louis, MO). Buthionine sulfoximine was pur- 
chased from Chemical Dynamics Corporation 
(South Plainfield, NJ) and anthglutin (l?-L-gluta- 
myl-2-(2carboxyphenyl)-hydrazine) was the 
generous gift of Dr M. Tanaka, Sankyo 
Laboratories, Tokyo, Japan. All other chemicals 
and reagents were of analytical grade, obtained 
from local commercial suppliers. 
Male Sprague-Dawley rats (150-250 g) were 
used throughout. In most experiments, animals 
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were treated with 0.6 mmol/kg diethylmaleate 
(DEM) in corn oil (20% w/v) 1 h prior to surgery. 
The rats were then anaesthetized with pentobar- 
bital and tracheostomized. The chest was opened 
and the pulmonary artery cannulated. The entire 
right ventricle and the right atrium together with 
most of the left ventricle were removed and the left 
atrium cannulated and secured with a ligature [ 121. 
The lung preparation was dissected free and placed 
in a negative pressure perfusion apparatus [ 131. 
The lungs were perfused in a recirculating system 
at a perfusion pressure of 7cmH20 and a flow rate 
of 9-10 ml/mm with a Krebs-Henseleit buffer (pH 
7.4) containing 2% bovine albumin, 5 mM glucose 
and 25 mM Hepes. The respiratory rate was 70 
cycles/min. Some experiments were performed us- 
ing a single pass perfusion with the same buffer 
and operating conditions. 
Following perfusion, the lungs were weighed 
and homogenized in perchloric acid (3% final con- 
centration). Samples were centrifuged to remove 
the precipitated protein and aliquots of the super- 
natant were derivatized for glutathione determina- 
tion according to the method of [14]. When the 
perfusion medium contained GSH or GSH precur- 
sors, the lungs were perfused for an extra 15 min 
with thiol- and disulfide-free buffer in a nonrecir- 
culating manner. 
3. RESULTS AND DISCUSSION 
Perfused lungs from control rats contained 
about 1 pM GSH per g wet weight at the beginning 
of the perfusion. Following perfusion with an 
amino acid-free medium for 60 min this figure was 
reduced by 20-30%. Prior treatment of animals 
with DEM resulted in -90% depletion of lung 
GSH. Perfusion of these lungs with an amino acid- 
free medium failed to increase the GSH content 
significantly. The inclusion of cysteine in the per- 
fusion medium was shown to support intracellular 
GSH synthesis with levels returning to -70% of 
control values after 60 min perfusion (table 1). It 
is apparent that the lung does not require addi- 
tional glycine or glutamate for its GSH biosyn- 
thesis and that the intracellular pools of these 
amino acids are adequate to ensure synthesis, at 
least for the limited perfusion times used in the 
present investigation. This also appears to be true 
for isolated hepatocytes [2], whereas in isolated 
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Table 1 
Replenishment of GSH in the perfused rat lung 
Conditions nmol GSH/g tissue 
(wet wt) 
Control 917 f 112 
DEM treated 70 f 25 
+ Cysteine, 1 mM 653 -I 17 
+ N-Acetylcysteine, 1 mM 509 f 55 
+ Methionine, 1 mM 106 f 45 
+ Cystine, 0.5 mM 248 f 63 
+ GSH, 1 mM 506 f 43 
+ GSH, 2.5 mM 533 f 19 
+ GSSG, 1.25 mM 225 f 24 
Perfusions were run for 60 min. Data are given as means 
f SD, n=3-5 
kidney cells GSH synthesis appears to depend at 
least partially on the availability of extracellular 
glycine and glutamate [6]. 
N-Acetylcysteine supplied in the perfusion 
medium was also shown to support GSH synthesis 
in the lung (table l), indicating the ability of the rat 
lung to deacetylate N-acetylcysteine to cysteine in 
this system. However, in the presence of methion- 
ine no GSH biosynthesis was observed, indicating 
that the rat lung lacks one or more of the enzymes 
involved in the cystathionase pathway. 
On the other hand, it seems that the rat lung has 
the capacity to reduce the disulfide bond in cystine. 
This has been noted for other cell types and, for in- 
stance, kidney cells can utilize cystine as efficiently 
as cysteine [5,6] for GSH biosynthesis. The lung 
apparently has only limited reduction capacity, 
with the efficiency of cystine in supporting GSH 
synthesis being only 40% that of cysteine. Whether 
or not cystine is taken up as the disulfide or re- 
duced during the uptake process is not clear. The 
reduction of cystine may occur via a sequence of 
reactions catalyzed by thioltransferases, as has 
been suggested to occur in the kidney [6]. 
The kidney has a high capacity to degrade 
glutathione and utilize the amino acids for in- 
tracellular GSH synthesis [IS]. It is apparent from 
our experiments that the rat lung also has this abili- 
ty and may readily utilize exogenous GSH as a 
source for intracellular GSH. In fact extracellular 
GSH was as effective as N-acetylcysteine in replen- 
ishing intracellular GSH. This replenishment was 
maximal at 1 mM GSH, which may reflect the 
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Fig.1. Replenishment of GSH in rat lung from DEM- 
treated rat perfused with a medium containing 1 mM 
GSH. 
rapid oxidation and disulfide formation in the 
recirculating system, and the rate of synthesis was 
- 10 nmol GSH/g per min (flg.1). 
The majority of the perfusions were done in a 
recirculating manner with rather high concentra- 
tions of thiols. This was more economical than 
single-pass perfusions with low substrate concen- 
trations - the high thiol levels being necessary due 
to disulfide formation. However, in order to show 
that this phenomenon of GSH uptake and resyn- 
thesis by the lung is relevant at physiological con- 
centrations, a small amount of single pass perfu- 
sions were performed with various concentrations 
of GSH and with 100 PM cysteine and N-acetyl- 
cysteine, for comparison (table 2). It can be seen 
that with single-pass perfusion, which more closely 
mimics the physiological situation, the lower con- 
centration of cysteine was almost as effective in 
supporting GSH resynthesis as was 1 mM cysteine 
in the recirculating system (tables 1,2). N-Acetyl- 
cysteine at 100 PM produced resynthesis of up to 
25% of the intracellular GSH in 1 h (table 2). 
Single pass perfusion with 25-1000 ,uM GSH 
resulted in various rates of resynthesis of in- 
tracellular GSH and this was saturated at 2OOpM 
extracellular GSH (table 2) (approx. 9 nmol GSH 
resynthesized/min). The concentration of GSH in 
rat hepatic vein has been found to be 21 pM 1161 
and at 25 PM GSH in the single-pass perfusion the 
Table 2 
Replenishment of GSH in the lung from DEM-treated 
rats using single-pass perfusion 
Conditions nmol GSH/g tissue 
(wet wt) 
+ Cysteine, 100,uM 608 
+ N-Acetylcysteine, 100 ,uM 228 
+ GSH, 25 /rM 199 
+ GSH, 50 /LM 257 
+ GSH, 200/4M 607 
+ GSH, 1 mM 538 
Perfusions were run for 60 min. Results represent 
duplicate determinations from one experiment in each 
case 
observed rate of intracellular GSH replenishment 
was approx. 2.15 nmol/min (table 2). It is likely 
that, had the perfusion period been longer, it may 
have been possible to observe complete replenish- 
ment of intracellular GSH from 25 ,uM extracel- 
lular GSH. 
Results of perfusion experiments using the y- 
glutamyl-transferase (y-gt) inhibitor anthglutin 
[17] and the y-glutamyl-cysteine synthetase in- 
hibitor buthionine sulphoximine (BSO) [ 181, in- 
dicate that the utilization of extracellular GSH is 
largely dependent upon breakdown and re-syn- 
thesis as opposed to direct uptake. In the presence 
of anthglutin, the GSH-dependent replenishment 
of intracellular GSH was inhibited by greater than 
50% (table 3), resulting presumably from the in- 
hibition of the breakdown of extracellular GSH so 
that the availability of the precursor amino acid 
becomes rate limiting. Alternatively, this observa- 
tion may be explained by anthglutin inhibition of 
y-gt-mediated uptake of GSH. 
Results obtained from experiments using BSO 
favor the idea of y-gt-mediated breakdown of ex- 
tracellular GSH followed by resynthesis intracell- 
ularly. Total inhibition of GSH replenishment by 
extracellular GSH and by other sulfur amino acids 
was achieved when BSO was included in the perfu- 
sion medium. BSO is regarded as a relatively 
specific inhibitor of y-glutamylcysteine synthetase, 
binding to the active site of the enzyme, and when 
administered in vivo has been shown to decrease 
GSH in most tissues investigated [19]. 
However, as indicated by findings of authors in 
[20], BSO may have other effects. They showed 
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Table 3 
Replenishment of GSH in the perfused lung from DEM 
treated rats 
Conditions nmol GSHlg tissue 
(wet wt) 
DEM treated 
+ Cysteine, 1 mM 
+ Cysteine + BSG, 0.5 mM 
+ GSH, 1 mM 
+ GSH + BSO, 0.5 mM 
+ GSH, 1 mM + anthglutin, 
0.2 mM 
70 f 25 
653 + 17 
109 f 48 
506 -+ 43 
48 f 39 
236 f 116 
Perfusions were run for 60 min. Data are given as means 
f SD, n = 3-5 
that the uptake of liposome entrapped GSH into 
liver and spleen was inhibited by BSO. Thus, one 
cannot exclude the possibility that BSO interferes 
with the uptake of GSH into the lung, even though 
it seems more likely that the effect of BSO is 
through i~bition of the resynthesis of GSH. 
In conclusion, it has been demonstrated that the 
isolated perfused rat lung synthesizes GSH when 
the sulfur amino acids cysteine and N-acetylcys- 
teine are supplied in the perfusion medium. The 
lung also has the capacity to utilize e~ra~~~~ 
GSH, probably through an extracellular break- 
down and resynthesis mechanism. This is in sup- 
port of previous findings where the conjugation of 
fluorodinitrobenzene in the perfused lung was in- 
creased in the presence of GSH in the perfusion 
medium [Ill. 
There is a considerable interorgan transport of 
glutathione. The circulating plasma levels of 
glutathione are quite high and found predominant- 
ly in the reduced form [8]. Liver appears to be the 
organ responsible for the ‘export’ of most of the 
GSH found in plasma, whereas the kidney utilizes 
plasma glutathione efficiently, since this organ has 
a high y-gt activity. About 2/3 of the plasma gluta- 
thione has been estimated to be utilized by the 
kidney [lo]. Our results indicate that the lung may 
utilize the major part of the remaining plasma 
glutathione. 
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